Landscapes / Companies
Livzon Pharmaceutical Group Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
None yet
Drugs
2
in active trials · 5 in all
Trials
2 active
11 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in South Korea | — | |||
| Also tested for | Reflux Esophagitis (RE) | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Circulatory Disease | ||||
| Open drug page | |||||
About
- No active trial
- LZM012, Recombinant SARS-CoV-2 Beta Variant Fusion Protein Vaccine/Recombinant SARS-CoV-2 Delta Variant Fusion Protein Vaccine, Recombinant SARS-CoV-2 Fusion Protein Vaccine
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021